APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical 3PL Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical 3PL Service Market Outlook and Growth Opportunities 2026

5 January 2026198 pages

Choose your research edition.

Industry ResearchPharmaceutical 3PL Service Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical 3PL Service Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Pharmaceutical 3PL Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical 3PL Service Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical 3PL Service Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Pharmaceutical 3PL Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical 3PL Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical 3PL Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical 3PL Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical 3PL Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical 3PL Service market include DHL, FedEx, UPS, Kuehne+Nagel, DB Schenker, CH Robinson, CEVA Logistics, Kerry Logistics and Agility, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical 3PL Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical 3PL Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical 3PL Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical 3PL Service market.

Pharmaceutical 3PL Service Segment by Company

DHL

FedEx

UPS

Kuehne+Nagel

DB Schenker

CH Robinson

CEVA Logistics

Kerry Logistics

Agility

Expeditors International of Washington Inc.

SF Express

AmerisourceBergen Corporation

EMS

Jd.Com, Inc.

Pharmaceutical 3PL Service Segment by Type

Transportation Service

Warehousing and Storage Service

Value-added Services

Pharmaceutical 3PL Service Segment by Application

SMEs

Large Enterprise

Pharmaceutical 3PL Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical 3PL Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical 3PL Service key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical 3PL Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical 3PL Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical 3PL Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical 3PL Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical 3PL Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical 3PL Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical 3PL Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical 3PL Service industry.

Chapter 3: Detailed analysis of Pharmaceutical 3PL Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical 3PL Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical 3PL Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical 3PL Service Industry Trends Table 2. Pharmaceutical 3PL Service Industry Drivers Table 3. Pharmaceutical 3PL Service Industry Opportunities and Challenges Table 4. Pharmaceutical 3PL Service Industry Restraints Table 5. Global Pharmaceutical 3PL Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical 3PL Service Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical 3PL Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical 3PL Service Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical 3PL Service Company, Product Type & Application Table 10. Global Pharmaceutical 3PL Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical 3PL Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Transportation Service Table 15. Significant Companies of Warehousing and Storage Service Table 16. Significant Companies of Value-added Services Table 17. Global Pharmaceutical 3PL Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Pharmaceutical 3PL Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Pharmaceutical 3PL Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Pharmaceutical 3PL Service Sales Value Share by Type (2021-2026) Table 21. Global Pharmaceutical 3PL Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of SMEs Table 23. Significant Companies of Large Enterprise Table 24. Global Pharmaceutical 3PL Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmaceutical 3PL Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pharmaceutical 3PL Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pharmaceutical 3PL Service Sales Value Share by Application (2021-2026) Table 28. Global Pharmaceutical 3PL Service Sales Value Share by Application (2027-2032) Table 29. Global Pharmaceutical 3PL Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pharmaceutical 3PL Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pharmaceutical 3PL Service Sales Value Share by Region (2021-2026) Table 32. Global Pharmaceutical 3PL Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pharmaceutical 3PL Service Sales Value Share by Region (2027-2032) Table 34. Global Pharmaceutical 3PL Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pharmaceutical 3PL Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pharmaceutical 3PL Service Sales Value Market Share by Country (2021-2026) Table 37. Global Pharmaceutical 3PL Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pharmaceutical 3PL Service Sales Value Market Share by Country (2027-2032) Table 39. DHL Company Information Table 40. DHL Business Overview Table 41. DHL Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. DHL Pharmaceutical 3PL Service Product Portfolio Table 43. DHL Recent Development Table 44. FedEx Company Information Table 45. FedEx Business Overview Table 46. FedEx Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. FedEx Pharmaceutical 3PL Service Product Portfolio Table 48. FedEx Recent Development Table 49. UPS Company Information Table 50. UPS Business Overview Table 51. UPS Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. UPS Pharmaceutical 3PL Service Product Portfolio Table 53. UPS Recent Development Table 54. Kuehne+Nagel Company Information Table 55. Kuehne+Nagel Business Overview Table 56. Kuehne+Nagel Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Kuehne+Nagel Pharmaceutical 3PL Service Product Portfolio Table 58. Kuehne+Nagel Recent Development Table 59. DB Schenker Company Information Table 60. DB Schenker Business Overview Table 61. DB Schenker Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. DB Schenker Pharmaceutical 3PL Service Product Portfolio Table 63. DB Schenker Recent Development Table 64. CH Robinson Company Information Table 65. CH Robinson Business Overview Table 66. CH Robinson Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. CH Robinson Pharmaceutical 3PL Service Product Portfolio Table 68. CH Robinson Recent Development Table 69. CEVA Logistics Company Information Table 70. CEVA Logistics Business Overview Table 71. CEVA Logistics Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. CEVA Logistics Pharmaceutical 3PL Service Product Portfolio Table 73. CEVA Logistics Recent Development Table 74. Kerry Logistics Company Information Table 75. Kerry Logistics Business Overview Table 76. Kerry Logistics Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Kerry Logistics Pharmaceutical 3PL Service Product Portfolio Table 78. Kerry Logistics Recent Development Table 79. Agility Company Information Table 80. Agility Business Overview Table 81. Agility Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Agility Pharmaceutical 3PL Service Product Portfolio Table 83. Agility Recent Development Table 84. Expeditors International of Washington Inc. Company Information Table 85. Expeditors International of Washington Inc. Business Overview Table 86. Expeditors International of Washington Inc. Pharmaceutical 3PL Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Expeditors International of Washington Inc. Pharmaceutical 3PL Service Product Portfolio Table 88. Expeditors International of Washington Inc. Recent Development Table 89. SF Express Company Information Table 90. SF Express Business Overview Table 91. SF Express Pharmaceutical 3PL Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. SF Express Pharmaceutical 3PL Service Product Portfolio Table 93. SF Express Recent Development Table 94. AmerisourceBergen Corporation Company Information Table 95. AmerisourceBergen Corporation Business Overview Table 96. AmerisourceBergen Corporation Pharmaceutical 3PL Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. AmerisourceBergen Corporation Pharmaceutical 3PL Service Product Portfolio Table 98. AmerisourceBergen Corporation Recent Development Table 99. EMS Company Information Table 100. EMS Business Overview Table 101. EMS Pharmaceutical 3PL Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. EMS Pharmaceutical 3PL Service Product Portfolio Table 103. EMS Recent Development Table 104. Jd.Com, Inc. Company Information Table 105. Jd.Com, Inc. Business Overview Table 106. Jd.Com, Inc. Pharmaceutical 3PL Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Jd.Com, Inc. Pharmaceutical 3PL Service Product Portfolio Table 108. Jd.Com, Inc. Recent Development Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Pharmaceutical 3PL Service Product Image Figure 2. Global Pharmaceutical 3PL Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical 3PL Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical 3PL Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Transportation Service Image Figure 8. Warehousing and Storage Service Image Figure 9. Value-added Services Image Figure 10. Global Pharmaceutical 3PL Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Pharmaceutical 3PL Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Pharmaceutical 3PL Service Sales Value Share by Type (2021-2032) Figure 13. SMEs Image Figure 14. Large Enterprise Image Figure 15. Global Pharmaceutical 3PL Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pharmaceutical 3PL Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceutical 3PL Service Sales Value Share by Application (2021-2032) Figure 18. Global Pharmaceutical 3PL Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pharmaceutical 3PL Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pharmaceutical 3PL Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pharmaceutical 3PL Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pharmaceutical 3PL Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pharmaceutical 3PL Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pharmaceutical 3PL Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pharmaceutical 3PL Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pharmaceutical 3PL Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pharmaceutical 3PL Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pharmaceutical 3PL Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pharmaceutical 3PL Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Transportation Service
  • Warehousing and Storage Service
  • Value-added Services
Applications
  • SMEs
  • Large Enterprise
Companies covered
  • DHL
  • FedEx
  • UPS
  • Kuehne+Nagel
  • DB Schenker
  • CH Robinson
  • CEVA Logistics
  • Kerry Logistics
  • Agility
  • Expeditors International of Washington Inc.
  • SF Express
  • AmerisourceBergen Corporation
  • EMS
  • Jd.Com, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical 3PL Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical 3PL Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical 3PL Service Market Dynamics
  1. 2.1 Pharmaceutical 3PL Service Industry Trends
  2. 2.2 Pharmaceutical 3PL Service Industry Drivers
  3. 2.3 Pharmaceutical 3PL Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical 3PL Service Industry Restraints
3 Pharmaceutical 3PL Service Market by Company
  1. 3.1 Global Pharmaceutical 3PL Service Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical 3PL Service Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical 3PL Service Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical 3PL Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical 3PL Service Company Product Type and Application
  6. 3.6 Global Pharmaceutical 3PL Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical 3PL Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical 3PL Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical 3PL Service Market by Type
  1. 4.1 Pharmaceutical 3PL Service Type Introduction
  2. 4.1.1 Transportation Service
  3. 4.1.2 Warehousing and Storage Service
  4. 4.1.3 Value-added Services
  5. 4.2 Global Pharmaceutical 3PL Service Sales Value by Type
  6. 4.2.1 Global Pharmaceutical 3PL Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Pharmaceutical 3PL Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Pharmaceutical 3PL Service Sales Value Share by Type (2021-2032)
5 Pharmaceutical 3PL Service Market by Application
  1. 5.1 Pharmaceutical 3PL Service Application Introduction
  2. 5.1.1 SMEs
  3. 5.1.2 Large Enterprise
  4. 5.2 Global Pharmaceutical 3PL Service Sales Value by Application
  5. 5.2.1 Global Pharmaceutical 3PL Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharmaceutical 3PL Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Pharmaceutical 3PL Service Sales Value Share by Application (2021-2032)
6 Pharmaceutical 3PL Service Regional Value Analysis
  1. 6.1 Global Pharmaceutical 3PL Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical 3PL Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical 3PL Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical 3PL Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical 3PL Service Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical 3PL Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical 3PL Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical 3PL Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical 3PL Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical 3PL Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical 3PL Service Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical 3PL Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical 3PL Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical 3PL Service Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical 3PL Service Country-level Value Analysis
  1. 7.1 Global Pharmaceutical 3PL Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical 3PL Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical 3PL Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical 3PL Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical 3PL Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical 3PL Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical 3PL Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DHL
  2. 8.1.1 DHL Company Information
  3. 8.1.2 DHL Business Overview
  4. 8.1.3 DHL Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 DHL Pharmaceutical 3PL Service Product Portfolio
  6. 8.1.5 DHL Recent Developments
  7. 8.2 FedEx
  8. 8.2.1 FedEx Company Information
  9. 8.2.2 FedEx Business Overview
  10. 8.2.3 FedEx Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 FedEx Pharmaceutical 3PL Service Product Portfolio
  12. 8.2.5 FedEx Recent Developments
  13. 8.3 UPS
  14. 8.3.1 UPS Company Information
  15. 8.3.2 UPS Business Overview
  16. 8.3.3 UPS Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 UPS Pharmaceutical 3PL Service Product Portfolio
  18. 8.3.5 UPS Recent Developments
  19. 8.4 Kuehne+Nagel
  20. 8.4.1 Kuehne+Nagel Company Information
  21. 8.4.2 Kuehne+Nagel Business Overview
  22. 8.4.3 Kuehne+Nagel Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kuehne+Nagel Pharmaceutical 3PL Service Product Portfolio
  24. 8.4.5 Kuehne+Nagel Recent Developments
  25. 8.5 DB Schenker
  26. 8.5.1 DB Schenker Company Information
  27. 8.5.2 DB Schenker Business Overview
  28. 8.5.3 DB Schenker Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 DB Schenker Pharmaceutical 3PL Service Product Portfolio
  30. 8.5.5 DB Schenker Recent Developments
  31. 8.6 CH Robinson
  32. 8.6.1 CH Robinson Company Information
  33. 8.6.2 CH Robinson Business Overview
  34. 8.6.3 CH Robinson Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CH Robinson Pharmaceutical 3PL Service Product Portfolio
  36. 8.6.5 CH Robinson Recent Developments
  37. 8.7 CEVA Logistics
  38. 8.7.1 CEVA Logistics Company Information
  39. 8.7.2 CEVA Logistics Business Overview
  40. 8.7.3 CEVA Logistics Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CEVA Logistics Pharmaceutical 3PL Service Product Portfolio
  42. 8.7.5 CEVA Logistics Recent Developments
  43. 8.8 Kerry Logistics
  44. 8.8.1 Kerry Logistics Company Information
  45. 8.8.2 Kerry Logistics Business Overview
  46. 8.8.3 Kerry Logistics Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kerry Logistics Pharmaceutical 3PL Service Product Portfolio
  48. 8.8.5 Kerry Logistics Recent Developments
  49. 8.9 Agility
  50. 8.9.1 Agility Company Information
  51. 8.9.2 Agility Business Overview
  52. 8.9.3 Agility Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Agility Pharmaceutical 3PL Service Product Portfolio
  54. 8.9.5 Agility Recent Developments
  55. 8.10 Expeditors International of Washington Inc.
  56. 8.10.1 Expeditors International of Washington Inc. Company Information
  57. 8.10.2 Expeditors International of Washington Inc. Business Overview
  58. 8.10.3 Expeditors International of Washington Inc. Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Expeditors International of Washington Inc. Pharmaceutical 3PL Service Product Portfolio
  60. 8.10.5 Expeditors International of Washington Inc. Recent Developments
  61. 8.11 SF Express
  62. 8.11.1 SF Express Company Information
  63. 8.11.2 SF Express Business Overview
  64. 8.11.3 SF Express Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 SF Express Pharmaceutical 3PL Service Product Portfolio
  66. 8.11.5 SF Express Recent Developments
  67. 8.12 AmerisourceBergen Corporation
  68. 8.12.1 AmerisourceBergen Corporation Company Information
  69. 8.12.2 AmerisourceBergen Corporation Business Overview
  70. 8.12.3 AmerisourceBergen Corporation Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AmerisourceBergen Corporation Pharmaceutical 3PL Service Product Portfolio
  72. 8.12.5 AmerisourceBergen Corporation Recent Developments
  73. 8.13 EMS
  74. 8.13.1 EMS Company Information
  75. 8.13.2 EMS Business Overview
  76. 8.13.3 EMS Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 EMS Pharmaceutical 3PL Service Product Portfolio
  78. 8.13.5 EMS Recent Developments
  79. 8.14 Jd.Com, Inc.
  80. 8.14.1 Jd.Com, Inc. Company Information
  81. 8.14.2 Jd.Com, Inc. Business Overview
  82. 8.14.3 Jd.Com, Inc. Pharmaceutical 3PL Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Jd.Com, Inc. Pharmaceutical 3PL Service Product Portfolio
  84. 8.14.5 Jd.Com, Inc. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst